Aerami Therapeutics
Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does Aerami Therapeutics use?+
Aerami Therapeutics uses 17 technologies including BugSnag, Shopify, Slick.
What industry is Aerami Therapeutics in?+
Aerami Therapeutics operates in the Biotechnology industry.
Where is Aerami Therapeutics based?+
Aerami Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026